- Home
- CELC vs INDV Comparison
CELC vs INDV Comparison
Compare CELC & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- INDV
- Stock Information
- Founded
- CELC 2011
- INDV 1994
- Country
- CELC United States
- INDV United States
- Employees
- CELC N/A
- INDV 1051
- Industry
- CELC Medical Specialities
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- CELC Health Care
- INDV Health Care
- Exchange
- CELC Nasdaq
- INDV Nasdaq
- Market Cap
- CELC 3.1B
- INDV 4.0B
- IPO Year
- CELC 2017
- INDV N/A
- Fundamental
- Price
- CELC $74.11
- INDV $31.87
- Analyst Decision
- CELC Strong Buy
- INDV Strong Buy
- Analyst Count
- CELC 5
- INDV 4
- Target Price
- CELC $69.40
- INDV $32.50
- AVG Volume (30 Days)
- CELC 1.4M
- INDV 2.3M
- Earning Date
- CELC 11-12-2025
- INDV 10-30-2025
- Dividend Yield
- CELC N/A
- INDV N/A
- EPS Growth
- CELC N/A
- INDV 111.35
- EPS
- CELC N/A
- INDV 0.59
- Revenue
- CELC N/A
- INDV $1,180,000,000.00
- Revenue This Year
- CELC N/A
- INDV N/A
- Revenue Next Year
- CELC N/A
- INDV $3.00
- P/E Ratio
- CELC N/A
- INDV $54.08
- Revenue Growth
- CELC N/A
- INDV N/A
- 52 Week Low
- CELC $7.58
- INDV $7.62
- 52 Week High
- CELC $83.00
- INDV $32.42
- Technical
- Relative Strength Index (RSI)
- CELC 64.02
- INDV 82.70
- Support Level
- CELC $71.06
- INDV $30.00
- Resistance Level
- CELC $79.97
- INDV $30.55
- Average True Range (ATR)
- CELC 5.13
- INDV 1.19
- MACD
- CELC 0.11
- INDV 0.74
- Stochastic Oscillator
- CELC 53.43
- INDV 92.65
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.